DOI 10.1016/j.cjca.2025.05.001
Prognostic Value of Angiography-Derived Index of Microcirculatory Resistance in Patients with Diabetes and ST-Segment Elevation Myocardial Infarction.
Аннотация
BACKGROUND
The occurrence of coronary microvascular dysfunction (CMD) after primary PCI in patients with diabetes mellitus (DM) and ST-elevation myocardial infarction (STEMI), and its impact on prognosis remains elusive.
METHODS
This single-centre retrospective observational study included 293 patients diagnosed with DM and STEMI. The coronary-angiography-derived index of microvascular resistance (caIMR) was calculated using the measurement software FlashAngio (Suzhou Rainmed Medical Technology Company, Ltd, Suzhou, Jiangsu, China), whereas cardiac magnetic resonance parameters were quantified using the postprocessing software Cvi42. CMD was defined as caIMR ≥ 25 U. The primary endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, nonfatal myocardial infarction, ischemia-driven revascularization, and heart failure.
RESULTS
MACE occurred in 86 patients (29.4%) during a median follow-up of 31 months. A significant correlation was identified between caIMR and both microvascular obstruction (MVO) (R = 0.61, P < 0.001) and infarct size (IS) (R = 0.39, P < 0.001). Furthermore, caIMR ≥ 25 was identified as an independent risk factor for MACE (hazard ratio [HR], 2.99; 95% confidence interval [CI], 1.78-5.03; P < 0.001). In addition, the integration of caIMR into risk modelling significantly improved prediction of MACE (net reclassification improvement 0.264, P < 0.001; integrated discrimination improvement 0.060, P < 0.001). Finally, the Kaplan-Meier survival curves displayed that patients with caIMR ≥ 25 were at a higher risk of MACE (log-rank P < 0.001).
CONCLUSIONS
The caIMR demonstrated a satisfactory correlation with CMR-determined MVO and IS in patients with DM and STEMI. Elevated caIMR was independently linked to a higher risk of MACE in patients with diabetes and STEMI post-PCI, serving as an effective predictor for MACE.
CLINICAL TRIAL REGISTRATION: XYFY2023-KL203-01.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.